SCHEMBL24039028

SCHEMBL24039028

CNC(=O)c1cc(F)cc(/C(N)=N/N=C\N)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 1/20 0.37
▸ HDAC8 Q9BY41 2/20 0.35
▸ HDAC6 Q9UBN7 2/20 0.35
▸ PLAU P00749 1/20 0.35
▸ NEU3 Q9UQ49 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ CES2 O00748 1/20 0.32
▸ CES1 P23141 1/20 0.32
▸ GRM5 P41594 1/20 0.31
▸ CA2 P00918 1/20 0.31
▸ HPGD P15428 3/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ F2 P00734 1/20 0.30
▸ F10 P00742 1/20 0.30
▸ PARP1 P09874 2/20 0.30
▸ TSHR P16473 1/20 0.30
▸ HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24022753 0.87 HDAC8 (0.36) HDAC8HDAC6PLAUNEU3NPC1
SCHEMBL24038958 0.84 PARP1 (0.41) KDM4ECES2CES1ALDH1A1PARP1
SCHEMBL22044403 0.84 KDM4E (0.44) KDM4ENPC1RAB9ACA2HPGD
SCHEMBL22043790 0.78 PRSS1 (0.33) NPC1RAB9AALDH1A1HTTSMN1; SMN2
SCHEMBL22043761 0.76 FURIN (0.33) —
SCHEMBL22043789 0.76 HCAR1 (0.43) —
SCHEMBL24022755 0.76 NEU3 (0.46) MAP4K4HDAC8HDAC6PLAUNEU3
SCHEMBL22044467 0.75 TAS1R3 (0.34) —
SCHEMBL22043764 0.75 CTSL (0.34) —
SCHEMBL114726 0.75 CES2 (0.54) MAP4K4HDAC8HDAC6PLAUNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021228992-A1 NUCLIDE LABELLED H-TETRAZINES AND USE THEREOF FOR PET AND SPECT PRETARGETED IMAGING AND RADIONUCLIDE THERAPY RIGSHOSPITALET (DK) 2021-11-18 — — WO disclosed
Send feedback